SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-13-056696
Filing Date
2013-12-12
Accepted
2013-12-12 17:49:59
Documents
1
Period of Report
2013-12-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4474
  Complete submission text file 0001209191-13-056696.txt   5841
Mailing Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6173416100
VERTEX PHARMACEUTICALS INC / MA (Issuer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY STREET CAMBRIDGE MA 02139
Business Address
Horton Kenneth L (Reporting) CIK: 0001552047 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19319 | Film No.: 131274472